References
- Quick A J. The prothrombin in hemophilia and in obstructive jaundice. J Biol Chem. 1935; 109: 73
- Bruck S D. Evaluation of Blood Compatibility of Polymeric Implants: Controlled Drug Delivery. CRC, Boca Raton, FL 1983; 2: 45–50
- Verstraete M, Clark P A., Wright I S. Use of different tissue thromboplastins in the control of anticoagulant therapy. Circulation. 1957; 16: 213–226
- von Schenck H, Jacobson M-L. Prothrombin assay standardized with an international normalization ratio (INR): goal and reality. Clin Chem. 1987; 33: 342
- Naghibi F, Han Y, Doods W J., Lawrence C E. Effects of reagent and instrument on prothrombin times, activated partial thromboplastin times and patient/control ratios. Thromb Haemost. 1988; 59: 445–463
- van den Besaelaar A MHP, Gralnick H R., Lewis S M. Thromboplastin Calibration and Oral Anti-coagulation Control. Martinua Nijhoff, The Hague 1984
- WHO, Geneva 1983, WHO Expert Committee on Biological Standardization. 33 Report. Tech Rep Ser 687
- Poller L. Progress in standardisation in anticoagulant control. Hematol Rev. 1987; 1: 225–241
- Wright D J., Jenkins D E. Simplified method for estimation of serum and plasma viscosity in multiple myeloma and related disorders. Blood. 1970; 36: 516–522
- Chandler W L., Schmer G. Evaluation of a new dynamic viscometer for measuring the viscosity of whole blood and plasma. Clin Chem. 1986; 32: 505–507
- Lindsley H, Teller D, Noonan B, Peterson M, Mannik M. Hyperviscosity syndrome in multiple myeloma. Am J Med. 1973; 54: 682–688
- Sawicki C A., Khaleque M A. Laser photolysis study of conformational change rates for hemoglobin in viscous solutions. Biophys J. 1983; 44: 191–199